Do renin–angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies

BACKGROUND: Renin–angiotensin system inhibitors (RAS inhibitors) are antihypertensive agents with potential antitumor effects. However, various studies have yielded conflicting results on the influence of RAS inhibitors on survival of cancer patients. The aim of this study was to evaluate the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hong, Li, Tao, Zhuang, Rongyuan, Cai, Weimin, Zheng, Yuanting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380250/
https://www.ncbi.nlm.nih.gov/pubmed/28353566
http://dx.doi.org/10.1097/MD.0000000000006394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380250/
https://www.ncbi.nlm.nih.gov/pubmed/28353566
http://dx.doi.org/10.1097/MD.0000000000006394

Ejemplares similares